BGI Genomics Co., Ltd.
300676.SZ - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$15.34B
Close$
$-0.17
100.5% downside
Current Fair Value
100.5% downsideOvervalued by 100.5% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $15.34 Billion |
|---|---|
| Enterprise Value | $14.02 Billion |
| Earnings per Share | $-1.48 |
| Beta | 0.66 |
| Outstanding Shares | 416,682,544 |
Return
| Return on Equity | -6.61% |
|---|---|
| Return on Assets | -4.91% |
| Return on Invested Capital | -5.43% |
Valuation & Multiples
| P/E Ratio | -28.07 |
|---|---|
| PEG | 25.38 |
| Price to Sales | 4.58 |
| Price to Book Ratio | 1.83 |
| Enterprise Value to Revenue | 3.76 |
| Enterprise Value to EBIT | -28.34 |
| Enterprise Value to Net Income | -26 |
| Total Debt to Enterprise | 0.1 |
| Debt to Equity | 0.16 |
Revenue Sources
No data
Last Earnings Call
Report Date
October 24, 2026
EPS
$0.01
ReportedRevenue
$904.49 M
Est. $904.49 MNext Earnings Call
Expected Date
April 26, 2027
EPS Estimate
-
Consensus analyst estimateRevenue Estimate
-
Consensus analyst estimateInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About BGI Genomics Co., Ltd.
3,580 employees
CEO: Yong Hou
BGI Genomics Co., Ltd. operates as an international supplier of genetic testing solutions and sequencing services. The company caters to a broad clientele, encompassing medical and research facilities, as well as other public and private...